Archive

AGM

The Company held its Annual General Meeting at its offices in Oxford on 13th December 2017 Click here to read more…

Director Dealing

The Company announces that it received notice today that the following Directors sold the following number of ordinary shares in the Company at the following…

Issue of Equity

Physiomics plc announces today that following the receipt of notice of exercise of employee options, 1,768,815 Ordinary Shares of 0.4p each in the Company (the…

Share Price Movement

Following the movement in the Physiomics share price today the Company would like to draw investors’ attention to its RNS of the 28th of November…

Completion of VT Clinical Project with Merck and announcement of Master Services Agreement

Physiomics plc (AIM: PYC) is pleased to announce that the human Virtual Tumour (“VT”) project with Merck, a leading science and technology company, first announced…

Dispatch of Annual Report and Shareholder Circular

  Dispatch of Documentation Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has published and posted…

Final Results for the year ended 30 June 2017

  Chairman’s Statement Summary of Results in the year ended 30 June 2017 Total income (revenue and grant income) decreased 9%…

Company Update

Physiomics plc (AIM: PYC) is pleased to announce positive developments relating to its core oncology and simulation business and to provide commentary on potential business…

Two new pre-clinical contracts

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has today signed two new contracts with a…

Physiomics to attend PAGE 2017

Oxford, UK, 6th June 2017: Physiomics is pleased to announce that it will attend the Population Approach Group Europe (PAGE) Annual Conference taking place in…